Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 50,100 shares at $144.85 ($7.2M) on 2020-12-10, disclosed to the SEC on 2020-12-17.
Open-market sale of $7.2M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.62 | 2,271 | $319K | 4.5% |
| 2 | $140.62 | 2,271 | $319K | 4.5% |
| 3 | $141.53 | 6,648 | $941K | 13.1% |
| 4 | $141.53 | 6,648 | $941K | 13.1% |
| 5 | $142.42 | 5,958 | $849K | 11.9% |
| 6 | $142.42 | 5,958 |
| $849K |
| 11.9% |
| 7 | $143.26 | 2,223 | $318K | 4.4% |
| 8 | $143.26 | 2,223 | $318K | 4.4% |
| 9 | $144.85 | 15,900 | $2.3M | 32.2% |
| Total | $142.87 avg | 50,100 | $7.2M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |